This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its structure, featuring a trifluoromethyl group, is particularly valuable in the development of drugs targeting the central nervous system, such as antidepressants and antipsychotics. The chiral nature of the molecule allows for the creation of enantiomerically pure compounds, enhancing the efficacy and reducing potential side effects of the resulting medications. Additionally, it is employed in research settings for the development of novel therapeutic agents and in the study of biochemical pathways involving amine-containing compounds. Its unique properties make it a versatile building block in medicinal chemistry.